Archive for the ‘Avandia’ Category

In an article published yesterday, we wrote that GlaxoSmithKline agreed to pay $3 billion in order to settle several federal investigations into its drug marketing practices, including Avandia its Type 2 diabetes drug that has been linked to cardiovascular injuries. According to Bloomberg Businessweek, a U.S. District

Bloomberg News has reported that GlaxoSmithKline has agreed to pay $3 billion to resolve federal investigations into the marketing of some of its drugs, including Type 2 diabetes drug Avandia. The deal with the U.S. Justice Department would account for GlaxoSmithKline’s largest legal settlement to date. The

Two Illinois plaintiffs have filed a lawsuit against GlaxoSmithKline alleging they should have never sold Avandia without warning consumers about the potential for serious side effects, such as heart attacks and congestive heart failure which the plaintiffs state they have suffered. The lawsuit was filed by the

A group of 8 plaintiffs have filed suit against against GlaxoSmithKline in Texas over alleged damage caused by Avandia. According to court filings, the plaintiffs allege that the use of Avandia caused them to suffer various heart and cardiovascular problems. The plaintiffs are seeking a full refund

GlaxoSmithKline Sued Over Alleged Avandia Injuries A group of 94 people have filed a lawsuit against GlaxoSmithKline, the maker of Avandia. The lawsuit, consisting of 14 counts, is seeking $700,000, including court costs, legal fees and other relief. In some cases, the plaintiffs are representing their deceased relatives.